JP2022505107A5 - - Google Patents

Info

Publication number
JP2022505107A5
JP2022505107A5 JP2021521016A JP2021521016A JP2022505107A5 JP 2022505107 A5 JP2022505107 A5 JP 2022505107A5 JP 2021521016 A JP2021521016 A JP 2021521016A JP 2021521016 A JP2021521016 A JP 2021521016A JP 2022505107 A5 JP2022505107 A5 JP 2022505107A5
Authority
JP
Japan
Prior art keywords
peptide
cell
antigen
chimeric molecule
molecule according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021521016A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022505107A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/078449 external-priority patent/WO2020079264A1/en
Publication of JP2022505107A publication Critical patent/JP2022505107A/ja
Publication of JP2022505107A5 publication Critical patent/JP2022505107A5/ja
Pending legal-status Critical Current

Links

JP2021521016A 2018-10-19 2019-10-18 キメラ分子 Pending JP2022505107A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18201560 2018-10-19
EP18201560.2 2018-10-19
PCT/EP2019/078449 WO2020079264A1 (en) 2018-10-19 2019-10-18 Chimeric molecules

Publications (2)

Publication Number Publication Date
JP2022505107A JP2022505107A (ja) 2022-01-14
JP2022505107A5 true JP2022505107A5 (cg-RX-API-DMAC7.html) 2022-10-24

Family

ID=63965155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021521016A Pending JP2022505107A (ja) 2018-10-19 2019-10-18 キメラ分子

Country Status (12)

Country Link
US (1) US20210324037A1 (cg-RX-API-DMAC7.html)
EP (1) EP3867268A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022505107A (cg-RX-API-DMAC7.html)
KR (1) KR20210081345A (cg-RX-API-DMAC7.html)
CN (1) CN112930355A (cg-RX-API-DMAC7.html)
AU (1) AU2019362400A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021007418A2 (cg-RX-API-DMAC7.html)
CA (1) CA3115007A1 (cg-RX-API-DMAC7.html)
EA (1) EA202191083A1 (cg-RX-API-DMAC7.html)
IL (1) IL282230A (cg-RX-API-DMAC7.html)
MX (1) MX2021004355A (cg-RX-API-DMAC7.html)
WO (1) WO2020079264A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109321569B (zh) * 2018-10-29 2022-04-12 迈杰转化医学研究(苏州)有限公司 一种引物探针组合物及其应用
EP4638712A2 (en) * 2022-12-22 2025-10-29 Bluesphere Bio, Inc. Methods for identifying t cell receptors (tcrs) that bind antigens

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2330678C (en) * 1998-05-11 2009-04-07 Miltenyi Biotec Gmbh Method of direct selection of antigen-specific t cells
ES2900004T3 (es) * 2013-08-05 2022-03-15 Immatics Biotechnologies Gmbh Nueva inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido el carcinoma de pulmón amicrocítico (NSCLC)
US20160177284A1 (en) * 2014-01-27 2016-06-23 Molecular Templates, Inc. Cell-targeted molecules comprising amino-terminus proximal or amino-terminal shiga toxin a subunit effector regions
CA2971408C (en) * 2014-12-17 2019-12-10 Sri International Targeted stealth liposomes loaded with an immunogenic human leukocyte antigen class i restricted peptide
JP6718450B2 (ja) * 2014-12-19 2020-07-08 イーティーエッチ チューリッヒ キメラ抗原受容体及びその使用方法
CN105504018B (zh) * 2016-01-13 2019-01-04 郑州大学 Lag-3亲和肽n13、制备方法及其应用
CN107286246B (zh) * 2016-12-28 2019-12-17 时力生物科技(北京)有限公司 治疗脑胶质瘤的嵌合抗原受体修饰的树突状细胞及其制备方法

Similar Documents

Publication Publication Date Title
US20250188145A1 (en) Tcr and peptides
US11001621B1 (en) Trifunctional T cell-antigen coupler and methods and uses thereof
JP6612963B2 (ja) 腫瘍抗原を直接認識するために組換えt細胞レセプターを使用するための組成物及び方法
Tsuji et al. Generation of tumor-specific, HLA class I–restricted human Th1 and Tc1 cells by cell engineering with tumor peptide–specific T-cell receptor genes
JP2021137024A5 (cg-RX-API-DMAC7.html)
JP2021521776A5 (cg-RX-API-DMAC7.html)
JP7687952B2 (ja) 血液腫瘍を治療するための遺伝子操作しているγδ-T細胞及び遺伝子操作していないγδ-T細胞に関する組成物及び方法
US20220119477A1 (en) Tcr and peptides
CN107995926B (zh) 嵌合抗原受体和使用方法
JP2018513683A5 (cg-RX-API-DMAC7.html)
WO2017222619A2 (en) Sequence arrangements and sequences for neoepitope presentation
EP3472205A1 (en) Chimeric antigen receptor
JP7227630B2 (ja) Y182t突然変異を有するt細胞-抗原カプラおよびその方法ならびに使用
US20210179686A1 (en) Cell sorting systems and methods of use
WO2021019474A1 (en) Mhc class ii molecules and methods of use thereof
JP7518915B2 (ja) Cd3融合タンパク質およびその使用
HK40058915A (en) Tcr and peptides